Insights on the Renal Biomarkers Global Market to 2027 – by Biomarker Type, Diagnostic Technique, End-user and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global renal biomarkers market reached a value of US$ 1.13 billion in 2021. Looking forward, the market is projected to reach a value of US$ 1.88 billion by 2027, exhibiting a CAGR … [Read more…]

Global Metabolomics Market Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F by Product & Service, Application, Indication, Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Metabolomics Global Market Report 2022, By Product & Service, By Application, By Indication, By Metabolomics Instruments, By Metabolomics Bioinformatics Tools & Services” report has been added to ResearchAndMarkets.com’s offering. The global metabolomics market is expected to grow from $2.35 billion in 2021 to $2.69 billion in 2022 at a compound annual growth rate … [Read more…]

Microbiome Global (FMT, Microbiome Drugs) Market Report 2022 Featuring Major Players – MicroBiome Therapeutics; Seres Therapeutics; Enterome Bioscience; Second Genome; Vedanta Biosciences – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Microbiome Global Market Report 2022: By Type, By Application, By Technology” report has been added to ResearchAndMarkets.com’s offering. The global microbiome market is expected to grow from $5.54 billion in 2021 to $6.18 billion in 2022 at a compound annual growth rate (CAGR) of 11.4%. The market is expected to reach $10.09 billion … [Read more…]

OneSpaWorld to Present at the Jefferies Consumer Conference

NEW YORK–(BUSINESS WIRE)–OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent global provider of health and wellness products and services on board cruise ships and in destination resorts around the world, will hold a virtual fireside chat presentation at the Jefferies Consumer Conference. The fireside chat presentation will be available on Monday, June 20, 2022 beginning at … [Read more…]

JATT Acquisition Corp. and Zura Bio Limited Announce Definitive Business Combination Agreement to Create NYSE Listed Biotechnology Company

Company advancing ZB-168, an anti-IL7Rα monoclonal antibody, originally developed by Pfizer Inc., in multiple phase 2 clinical trials The transaction values the combined companies at a pro forma enterprise value of $215 million Total gross proceeds of up to $189 million of which up to $139 million is from the cash held in trust (assuming … [Read more…]

The AmerisourceBergen Foundation Commits $150,000 to Equitable Vaccination Efforts Across the Globe

Funding will support the United Nations Foundation’s Shot@Life, a grassroots advocacy campaign that champions global immunization CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community, has committed $150,000 to the United Nations Foundation’s Shot@Life campaign to support vaccine equity, protecting the world’s most … [Read more…]

Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA)

–          Sizable and sustained improvement in Hammersmith Functional Motor Scale-Expanded (HFMSE) scores observed at 24 months –          Substantial increase in Revised Upper Limb Module (RULM) scores observed at 24 months –          No serious safety risks identified over 24 months –          Enrollment progressing in pivotal Phase 3 SAPPHIRE registrational trial –          Scholar Rock to host webcast today … [Read more…]

Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration

– Submission seeks approval of momelotinib for the treatment of myelofibrosis – SAN MATEO, Calif.–(BUSINESS WIRE)–Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for momelotinib, … [Read more…]

Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for the Second Quarter 2022 Earnings Release and Conference Call

MILWAUKEE–(BUSINESS WIRE)–Physicians Realty Trust (NYSE:DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized, and the Company has declared, a quarterly cash dividend of $0.23 per common share and unit for the quarter ending June 30, 2022. “We are proud to declare and pay our 36th consecutive quarterly dividend. Cash flows from … [Read more…]

Worldwide High-flow Nasal Cannula Industry to 2027 – Rising Incidence of Respiratory Disorders is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “High-flow Nasal Cannula Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The High-flow Nasal Cannula market is projected to grow with a CAGR of nearly 12.4% over the forecast period. Companies Mentioned ResMed Fisher & Paykel Healthcare Limited Devatec Teleflex Incorporated Smiths Medical … [Read more…]